Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Design, Prospective, Phase II Clinical Trial to Evaluate the Safety and Efficacy of GV1001, a novel peptide mimicking human telomerase reverse transcriptase, for the Treatment of Moderate to Severe Alzheimer’s Disease
- Authors
- 고성호
- Issue Date
- 4-Dec-2019
- Place
- San Diego, California, USA
- Conference Name
- the 12th edition of Clinical Trials on Alzheimer’s Disease
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 신경과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Koh, Seong-Ho
- 서울 의과대학 (DEPARTMENT OF NEUROLOGY)